Skip to search formSkip to main contentSkip to account menu

MK 458

Known as: 2H-Naphth(1,2-b)-1,4-oxazin-9-ol, 3,4,4a,5,6,10b-hexahydro-4-propyl-, hydrochloride, (4aR-trans)-, MK-458 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1993
1993
To the Editor. —We were pleased to read the article entitled "Dopamine Agonist Treatment of Fluctuating Parkinsonism," 1 which… 
1991
1991
SummaryThe potent and selective dopamine D-2 agonist, MK-458 [PHNO; ( + )-4-propyl-9-hydroxynaphthoxazine] was administered as… 
1991
1991
Ninety-four patients with early Parkinson's disease were investigated in a double-blind, placebo-controlled evaluation of MK-458… 
1988
1988
MK 458 is a potent and selective D2 receptor agonist. MK 458 consists of (+)-4-propyl-9-hydroxynaphthoxazine (PHNO) in a…